MACRO GROUP PHARMACEUTICALS (MACRO CAPITAL) S.A.E |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.847 EGP | +0.87% |
|
-5.28% | -37.39% |
| Sales 2022 | 730M 15.22M | Sales 2023 | 526M 10.97M | Capitalization | 1.68B 35.08M |
|---|---|---|---|---|---|
| Net income 2022 | 174M 3.63M | Net income 2023 | -273M -5.69M | EV / Sales 2022 | 2.59 x |
| Net Debt 2022 | 16.96M 354K | Net Debt 2023 | 151M 3.15M | EV / Sales 2023 | 3.48 x |
| P/E ratio 2022 |
10.9
x | P/E ratio 2023 |
-6.1
x | Employees | - |
| Yield 2022 |
3.25% | Yield 2023 |
-
| Free-Float | 28.93% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.87% | ||
| 1 week | -5.28% | ||
| Current month | -7.65% | ||
| 1 month | -4.79% | ||
| 3 months | -28.13% | ||
| 6 months | -39.44% | ||
| Current year | -37.39% |
1 week
1.80
1.97
1 month
1.802.08
Current year
1.803.84
1 year
1.803.84
3 years
1.805.28
5 years
1.805.28
10 years
1.805.28
| Managers | Title | Age | Since |
|---|---|---|---|
Hisham Wasfy
CEO | Chief Executive Officer | - | 19-11-30 |
Ashraf Hamdy
DFI | Director of Finance/CFO | - | 19-06-30 |
Zeina Shahin
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Sahar El-Sallab
BRD | Director/Board Member | - | 20-12-31 |
Ahmed Badreldin
BRD | Director/Board Member | 52 | 20-12-31 |
Ahmed El-Nayeb
FOU | Founder | - | 01-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-07-10 | 1.847 | +0.87% | 1,648,053 |
| 24-07-09 | 1.831 | -3.68% | 2,401,016 |
| 24-07-08 | 1.901 | -0.99% | 1,561,492 |
| 24-07-07 | 1.92 | -1.54% | 1,991,910 |
| 24-07-04 | 1.95 | 0.00% | 1,511,557 |
End-of-day quote Egyptian Exchange, July 09, 2024
More quotes
Macro Group Pharmaceutical S.A.E. (Macro Capital) is specialized in developing, manufacturing and marketing pharmaceuticals. The company's products include anti-scar, skincare, antiseptic, hair care, oral care and muscle relaxant medicines. In addition, the group offers plant-based medicines.
At the end of 2021, Macro Group Pharmaceutical S.A.E. (Macro Capital) had one production site in Egypt.
Sector
Pharmaceuticals
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -37.39% | 21.67M | |
| +62.64% | 841B | |
| +40.42% | 625B | |
| -3.80% | 360B | |
| +17.64% | 327B | |
| +10.40% | 300B | |
| +15.66% | 242B | |
| +17.90% | 227B | |
| +15.77% | 174B | |
| +1.02% | 162B |
- Stock Market
- Equities
- MCRO Stock
